Atlas FDA

Belotero Balance (+) Lidocaine Dermal Filler

FDA premarket approval P090016/S068 · decided 2025-10-24

Approval details

PMA number
P090016
Supplement
S068
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Belotero Balance (+) Lidocaine Dermal Filler
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2025-09-26
Decision date
2025-10-24
Days to decision
28 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
modifications to the assay for determining the concentration of lidocaine hydrochloride and its impurities.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29